Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pherin Pharmaceuticals Inc.
DescriptionNasally administered vomeropherin compound
Molecular Target Not available
Mechanism of ActionUnknown
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationPremenstrual syndrome (PMS)
Indication DetailsTreat premenstrual syndrome (PMS); Treat symptoms of premenstrual syndrome (PMS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today